David Aviezer - Net Worth and Insider Trading
David Aviezer Net Worth
The estimated net worth of David Aviezer is at least $0 dollars as of 2024-05-04. David Aviezer is the President & CEO of Protalix BioTherapeutics Inc and owns about 0 shares of Protalix BioTherapeutics Inc (PLX) stock worth over $0. Details can be seen in David Aviezer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David Aviezer has not made any transactions after 2012-05-02 and currently still holds the listed stock(s).
Transaction Summary of David Aviezer
David Aviezer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Aviezer owns 1 companies in total, including Protalix BioTherapeutics Inc (PLX) .
Click here to see the complete history of David Aviezer’s form 4 insider trades.
Insider Ownership Summary of David Aviezer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PLX | Protalix BioTherapeutics Inc | 2012-05-02 | director & President & CEO |
David Aviezer Latest Holdings Summary
David Aviezer currently owns a total of 1 stock. David Aviezer owns 0 shares of Protalix BioTherapeutics Inc (PLX) as of May 2, 2012, with a value of $0.
Latest Holdings of David Aviezer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics Inc | 2012-05-02 | 0 | 1.14 | 0 |
Holding Weightings of David Aviezer
David Aviezer Form 4 Trading Tracker
According to the SEC Form 4 filings, David Aviezer has made a total of 0 transactions in Protalix BioTherapeutics Inc (PLX) over the past 5 years. The most-recent trade in Protalix BioTherapeutics Inc is the sale of 45,000 shares on May 2, 2012, which brought David Aviezer around $3 Million.
Insider Trading History of David Aviezer
- 1
David Aviezer Trading Performance
David Aviezer Ownership Network
David Aviezer Owned Company Details
What does Protalix BioTherapeutics Inc do?
Who are the key executives at Protalix BioTherapeutics Inc?
David Aviezer is the director & President & CEO of Protalix BioTherapeutics Inc. Other key executives at Protalix BioTherapeutics Inc include director & President and CEO Dror Bashan , 10 percent owner Dexcel Pharma Technologies Ltd. , and 10 percent owner Dan Oren .
Protalix BioTherapeutics Inc (PLX) Insider Trades Summary
Over the past 18 months, David Aviezer made no insider transaction in Protalix BioTherapeutics Inc (PLX). Other recent insider transactions involving Protalix BioTherapeutics Inc (PLX) include a net purchase of 110,000 shares made by Aharon Schwartz , and a net purchase of 64,516 shares made by Dror Bashan .
In summary, during the past 3 months, insiders sold 0 shares of Protalix BioTherapeutics Inc (PLX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Protalix BioTherapeutics Inc (PLX) were sold and 174,516 shares were bought by its insiders, resulting in a net purchase of 174,516 shares.
Protalix BioTherapeutics Inc (PLX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protalix BioTherapeutics Inc Insider Transactions
David Aviezer Mailing Address
Above is the net worth, insider trading, and ownership report for David Aviezer. You might contact David Aviezer via mailing address: C/o Protalix Biotherapeutics, Inc., 2 Snunit St, Science Park, Pob 455, Carmiel L3 20100.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
